496 related articles for article (PubMed ID: 30942513)
21. Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?
Lenoir C; El Biali M; Luthy C; Grosgurin O; Desmeules JA; Rollason V
Int J Clin Pharm; 2019 Dec; 41(6):1634-1641. PubMed ID: 31664687
[TBL] [Abstract][Full Text] [Related]
22. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
Craig DG; Thimappa R; Anand V; Sebastian S
QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
[TBL] [Abstract][Full Text] [Related]
23. The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.
Kelly OB; Dillane C; Patchett SE; Harewood GC; Murray FE
Dig Dis Sci; 2015 Aug; 60(8):2280-6. PubMed ID: 25840918
[TBL] [Abstract][Full Text] [Related]
24. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitors: why this gap between guidelines and prescribing practices in geriatrics?
Michelon H; Delahaye A; Fellous L; Davido B; Dinh A; Le Quintrec JL; Teillet L; Herr M
Eur J Clin Pharmacol; 2019 Sep; 75(9):1327-1329. PubMed ID: 31129732
[No Abstract] [Full Text] [Related]
26. National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012).
Blank ML; Parkin L
J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):179-184. PubMed ID: 28403034
[TBL] [Abstract][Full Text] [Related]
27. Relevance of proton pump inhibitors prescriptions in a tertiary care hospital in Lebanon.
Souaid CK; Maalouf RG; Hallit S; Akiki B; Dagher E
Arab J Gastroenterol; 2020 Sep; 21(3):194-198. PubMed ID: 32830092
[TBL] [Abstract][Full Text] [Related]
28. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
Luo H; Fan Q; Xiao S; Chen K
BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
[TBL] [Abstract][Full Text] [Related]
29. Reasons for initiation of proton pump inhibitor therapy for hospitalised patients and its impact on outpatient prescription in primary care.
Villamañán E; Ruano M; Lara C; Suárez-de-Parga JM; Armada E; Álvarez-Sala R; Pérez E; Herrero A
Rev Esp Enferm Dig; 2015 Nov; 107(11):652-8. PubMed ID: 26541654
[TBL] [Abstract][Full Text] [Related]
30. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
Abrams TE; Lund BC; Bernardy NC; Friedman MJ
Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of the use of proton pump inhibitors in primary health care].
Hernández-Arroyo MJ; Díaz-Madero A; Enríquez-Gutiérrez E; Teijeiro-Bermejo MC; Sáez-Rodríguez E; Gutiérrez-Martín MR
Semergen; 2018; 44(5):316-322. PubMed ID: 29153640
[TBL] [Abstract][Full Text] [Related]
32. Gastroesophageal reflux guidelines: the European experience.
McCracken M
J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):395-6. PubMed ID: 24795980
[No Abstract] [Full Text] [Related]
33. Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptions.
Pasina L; Nobili A; Tettamanti M; Riva E; Lucca U; Piccinelli R; Defendi L; Perego L; Lucifora S; Bulla C
Int J Clin Pharmacol Ther; 2010 Nov; 48(11):735-43. PubMed ID: 20979932
[TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
Liu Y; Zhu X; Li R; Zhang J; Zhang F
BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
[TBL] [Abstract][Full Text] [Related]
35. Noncompliance with NASPGHAN-ESPGHAN practice guidelines for GER in Europe: is there a point?
Thaler MM
J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):396-7. PubMed ID: 24795982
[No Abstract] [Full Text] [Related]
36. Evaluation of a Trainee-Led Project to Reduce Inappropriate Proton Pump Inhibitor Infusion in Patients With Upper Gastrointestinal Bleeding: Skip the Drips.
Coronel E; Bassi N; Donahue-Rolfe S; Byrne E; Sokol S; Reddy G; Arora VM
JAMA Intern Med; 2017 Nov; 177(11):1687-1689. PubMed ID: 29052711
[TBL] [Abstract][Full Text] [Related]
37. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
[TBL] [Abstract][Full Text] [Related]
38. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
[TBL] [Abstract][Full Text] [Related]
39. How do Swiss general practitioners agree with and report adhering to a top-five list of unnecessary tests and treatments? Results of a cross-sectional survey.
Selby K; Cornuz J; Cohidon C; Gaspoz JM; Senn N
Eur J Gen Pract; 2018 Dec; 24(1):32-38. PubMed ID: 29168409
[TBL] [Abstract][Full Text] [Related]
40. Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications.
Niaz Q; Godman B; Campbell S; Kibuule D
Int J Clin Pharm; 2020 Aug; 42(4):1227-1236. PubMed ID: 32458227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
